Autologous Adoptive Immunotherapy (AAIT) of Natural Killer Cells
What is AAIT?
Our Autologous Adoptive Immunotherapy (AAIT) is a type of therapy that is only available in our Mexico center that hasn’t been approved by the FDA for the treatment of cancer within the United States. AAIT utilizes a targeted natural killer cell treatment using the patient’s own immune system aimed towards fighting cancer.
With nearly a decade of experience in treating the most difficult cancers, we have developed one of the most innovative immune-based cancer treatment therapies. AAIT is our proprietary method of helping cancer patients achieve stronger immune systems by supplementing their bodies with healthy immune cells that have the ability to fight cancer. In essence, AAIT is akin to an immune system transplant. Unlike organ transplants, in which organs are obtained from one person and given to another, the cells that are transplanted in the AAIT process are autologous, which means they are the patient’s own cells.
This content is only available at our international center located in Hermosillo, Mexico. Click here to securely view the article on www.envitamexico.mx
The following featured articles will help you better understand our unique approach to cancer treatment as well as provide essential steps to success:
Please Note: This treatment is not available in United States and is not FDA approved. It is offered through Envita Medical Centers of Mexico and is administered and overseen by our international group of doctors.